We use analytics and advertising cookies, which you can accept or reject; see our privacy policy.

Current choice:

MTH1

MTH1 inhibitors and degraders target nudix hydrolase 1 (NUDT1, also called MTH1), which removes oxidized nucleotides. MTH1 hydrolyzes oxidized precursors such as 8-oxo-2'-deoxyguanosine triphosphate (8-oxo-dGTP), which keeps them out of newly synthesized DNA. In 2014 TH588 and TH287 were introduced as MTH1 inhibitors that increase oxidative damage in cancer cell DNA. A second 2014 study showed that (S)-crizotinib, the enantiomer of the anaplastic lymphoma kinase (ALK) inhibitor crizotinib, binds MTH1 stereospecifically. Later selective inhibitors such as BAY-707 and IACS-4619 were used to reexamine whether MTH1 inhibition alone reduces cancer cell survival. SU0383 inhibits both MTH1 and 8-oxoguanine DNA glycosylase 1 (OGG1). aTAG 4531 and aTAG 2139 are MTH1-binding degraders used to remove MTH1-tagged fusion proteins in targeted degradation studies.

2 Items

  • MTH1 activator-1
    Cat. No.
    A37982
    CAS No.
    2803422-60-6

    MTH1 activator-1

    MTH1 activator-1 is a potent activator of MTH1, a critical enzyme involved in the repair of oxidative damage to nucleotide pools. This compound significantly enhances endogenous MTH1 activity, leading to reduced levels of 8-oxo-dG in cellular DNA. MTH1 activator-1 serves as a valuable tool for investigating the cellular and biological implications of enhanced oxidative damage repair, and it may provide insights into strategies for delaying or preventing tumorigenesis.

    In stock View Details
    5 mg
    $215.00
    10 mg
    $355.00
    All 5 sizes
  • MTH1 ligand 1
    Cat. No.
    A38441
    CAS No.
    2412986-35-5

    MTH1 ligand 1

    MTH1 Ligand 1 is a specific ligand that targets the MTH1 protein, playing a crucial role in cellular pathways associated with nucleotide metabolism and cancer cell survival. This compound is instrumental in the synthesis of PROTAC aTAG 2139, facilitating targeted protein degradation in research applications. Its selectivity for MTH1 makes it a valuable tool for investigating therapeutic strategies aimed at mitigating oncogenic processes.

    View Details

    Out of stock

    All 3 sizes

2 Items

Added to your cart

View Cart Checkout

    Loading...